Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer’s disease in intracerebroventricular streptozotocin model for brain delivery

References

• Rahman SO, Panda BP, Parvez S, et al. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease. Biomed Pharmacother. 2019;110:47–58.
   PubMed Web of Science ®Google Scholar
• Zameer S, Najmi AK, Vohora D, et al. Bisphosphonates: future perspective for neurological disorders. Pharmacol Rep. 2018;70:900–907.
   PubMed Web of Science ®Google Scholar
• Khan AR, Liu M, Khan MW, et al. Progress in brain targeting drug delivery system by nasal route. J Control Release. 2017;268:364–389.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev. 2012;64(7):640–665.
   PubMed Web of Science ®Google Scholar
• Barcia E, Boeva L, García-García L, et al. Nanotechnology-based drug delivery of ropinirole for Parkinson's disease. Drug Deliv. 2017;24(1):1112–1123.
   PubMed Web of Science ®Google Scholar
• Jafarieh O, Md S, Ali M, et al. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting. Drug Dev Ind Pharm. 2015;41(10):1674–1681.
   PubMed Web of Science ®Google Scholar
• Karthivashan G, Ganesan P, Park S-Y, et al. Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease. Drug Deliv. 2018;25(1):307–320.
   PubMed Web of Science ®Google Scholar
• Nayak AK, Pal D. Chitosan-based interpenetrating polymeric network systems for sustained drug release. AdvTheranos Mater. 2015;75:183–208.
   Google Scholar
• Sreekumar S, Goycoolea FM, Moerschbacher BM, et al. Parameters influencing the size of chitosan-TPP nano- and microparticles. Sci Rep. 2018;8(1):4695.
   PubMedGoogle Scholar
• Rassu G, Porcu E, Fancello S, et al. Intranasal delivery of genistein-loaded nanoparticles as a potential preventive system against neurodegenerative disorders. Pharmaceutics. 2018;11(1):8.
   PubMed Web of Science ®Google Scholar
• Bari NK, Fazil M, Hassan MQ, et al. Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder. Int J Biol Macromol. 2015;81:49–59.
   PubMed Web of Science ®Google Scholar
• Fazil M, Md S, Haque S, et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 2012;47(1):6–15.
   PubMed Web of Science ®Google Scholar
• Chang KH, Chung CJ, Lin CL, et al. Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis. Age (Dordr). 2014;36(2):967–975.
   PubMedGoogle Scholar
• Cibickova I, Hyšpler R, Cibiček N, et al. Alendronate lowers cholesterol synthesis in the central nervous system of rats – a preliminary study. Physiol Res. 2009;58:455–458.
   PubMed Web of Science ®Google Scholar
• Cibičková L, Palička V, Cibiček N, et al. Differential effects of statins and alendronate on cholinesterases in serum and brain of rats. Physiol Res. 2007;56:765–770.
   PubMed Web of Science ®Google Scholar
• Dunford JE, Thompson K, Coxon FP, et al. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther. 2001;296(2):235–242.
   PubMed Web of Science ®Google Scholar
• Zameer S, Kaundal M, Vohora D, et al. Ameliorative effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with emphasis on Aβ and BACE-1. Neurotoxicology. 2019;70:122–134.
   PubMed Web of Science ®Google Scholar
• Zameer S, Alam M, Hussain S, et al. Neuroprotective role of alendronate against APP processing and neuroinflammation in mice fed a high fat diet. Brain Res Bull. 2020;161:197–212.
   PubMed Web of Science ®Google Scholar
• Mittal D, Ali A, Md S, et al. Insights into direct nose to brain delivery: current status and future perspective. Drug Deliv. 2014;21(2):75–86.
   PubMed Web of Science ®Google Scholar
• Kuljanin J, Janković I, Nedeljković J, et al. Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe (III) ions. J Pharm Biomed Anal. 2002;28(6):1215–1220.
   PubMed Web of Science ®Google Scholar
• Gomathi T, Sudha P, Florence JAK, et al. Fabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method. Int J Biol Macromol. 2017;104(Pt B):1820–1832.
   PubMedGoogle Scholar
• Hanson LH, Fine JM, Svitak AL, et al. Intranasal administration of CNS therapeutics to awake mice. J Vis Exp. 2013;74:4440.
   Google Scholar
• Nabi B, Rehman S, Fazil M, et al. Riluzole loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress. Drug Dev Ind Pharm. 2020;46:1–42.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang J, Guo Y, et al. A novel HPLC-UV method for determining alendronate in rat plasma through precolumn derivatization with phenyl isothiocyanate: application to pharmacokinetics. J Liq Chromatogr R T. 2016;39(17–18):815–820.
   Web of Science ®Google Scholar
• Tabrizian K, Yazdani A, Baheri B, et al. Zinc chloride and lead acetate-induced passive avoidance memory retention deficits reversed by nicotine and bucladesine in mice. Biol Trace Elem Res. 2016;169(1):106–113.
   PubMed Web of Science ®Google Scholar
• Vohora D, Pal SN, Pillai KK. Modulation of spontaneous alternation performance of mice treated with thioperamide and tacrine in a cross maze task. Fundam Clin Pharmacol. 2005;19(5):531–532.
   PubMed Web of Science ®Google Scholar
• Zameer S, Vohora D. Effect of aromatase inhibitors on learning and memory and modulation of hippocampal dickkopf-1 and sclerostin in female mice. Pharmacol Rep. 2017;69:1300–1307.
   PubMed Web of Science ®Google Scholar
• Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–858.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Reeta KH, Singh D, Gupta YK. Edaravone attenuates intracerebroventricular streptozotocin-induced cognitive impairment in rats. Eur J Neurosci. 2017;45:987–997.
   PubMed Web of Science ®Google Scholar
• Wang D, Wang C, Liu L, et al. Protective effects of evodiamine in experimental paradigm of Alzheimer's disease. Cogn Neurodyn. 2018;12(3):303–313.
   PubMed Web of Science ®Google Scholar
• Ayyub M, Najmi A, Akhtar M. Protective effect of irbesartan an angiotensin (AT1) receptor antagonist in unpredictable chronic mild stress induced depression in mice. Drug Res (Stuttg). 2017;67(1):59–64.
   PubMed Web of Science ®Google Scholar
• Richa R, Yadawa AK, Chaturvedi CM. Hyperglycemia and high nitric oxide level induced oxidative stress in the brain and molecular alteration in the neurons and glial cells of laboratory mouse, Mus musculus. Neurochem Int. 2017;104:64–79.
   PubMed Web of Science ®Google Scholar
• Wu D, Yotnda P. Production and detection of reactive oxygen species (ROS) in cancers. J Vis Exp. 2011;(57):3357.
   Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–275.
   PubMed Web of Science ®Google Scholar
• Hou DR, Wang Y, Zhou L, et al. Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease. Chin Med J. 2008;121:2320–2323.
   PubMed Web of Science ®Google Scholar
• Singh B, Sharma B, Jaggi AS, et al. Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer’s disease type: possible involvement of PPAR-γ agonistic property. J Renin Angiotensin Aldosterone Syst. 2013;14(2):124–136.
   PubMed Web of Science ®Google Scholar
• Nafee N, Zewail M, Boraie N. Alendronate-loaded, biodegradable smart hydrogel: a promising injectable depot formulation for osteoporosis. J Drug Target. 2018;26(7):563–575.
   PubMed Web of Science ®Google Scholar
• Thoke S, Sharma P, Rawat Y, et al. Formulation development & evaluation of effervescent tablet of alendronate sodium with vitamin D 3. J Drug Deliv Ther. 2013;3:65–74.
   Google Scholar
• Fan W, Yan W, Xu Z, et al. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerfaces. 2012;90:21–27.
   PubMed Web of Science ®Google Scholar
• Al-Nemrawi N, Alsharif SSM, Dave R. Preparation of chitosan-tpp nanoparticles: the influence of chitosan polymeric properties and formulation variables. Int J App Pharm. 2018;10(5):60.
   PubMedGoogle Scholar
• Yang HC, Hon MH. The effect of the molecular weight of chitosan nanoparticles and its application on drug delivery. Microchem J. 2009;92(1):87–91.
   Web of Science ®Google Scholar
• Miladi K, Sfar S, Fessi H, et al. Encapsulation of alendronate sodium by nanoprecipitation and double emulsion: from preparation to in vitro studies. Ind Crops Prod. 2015;72:24–33.
   Web of Science ®Google Scholar
• Koulouktsi C, Nanaki S, Barmpalexis P, et al. Preparation and characterization of Alendronate depot microspheres based on novel poly(-ε-caprolactone)/Vitamin E TPGS copolymers. Int J Pharm X. 2019;1:100014.
   PubMedGoogle Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37–42.
   Google Scholar
• Tzeyung AS, Md S, Bhattamisra SK, et al. Fabrication, optimization, and evaluation of rotigotine-loaded chitosan nanoparticles for nose-to-brain delivery. Pharmaceutics. 2019;11(1):26.
   PubMed Web of Science ®Google Scholar
• Samson G, de la Calera AG, Dupuis-Girod S, et al. Ex vivo study of bevacizumab transport through porcine nasal mucosa. Eur J Pharm Biopharm. 2012;80:465–469.
   PubMed Web of Science ®Google Scholar
• Shah B, Khunt D, Misra M, et al. Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route. Int J Biol Macromol. 2016;89:206–218.
   PubMed Web of Science ®Google Scholar
• Erdő F, Bors LA, Farkas D, et al. Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res Bull. 2018;143:155–170.
   PubMed Web of Science ®Google Scholar
• Yasir M, Sara UVS. Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation. Acta Pharm Sin B. 2014;4:454–463.
   PubMed Web of Science ®Google Scholar
• Yamini P, Ray R, Chopra K. Vitamin D3 attenuates cognitive deficits and neuroinflammatory responses in ICV-STZ induced sporadic Alzheimer’s disease. Inflammopharmacology. 2018;26(1):39–55.
   PubMed Web of Science ®Google Scholar
• Li D, Huang Y, Cheng B, et al. Streptozotocin induces mild cognitive impairment at appropriate doses in mice as determined by long-term potentiation and the Morris water maze. J Alzheimers Dis. 2016;54(1):89–98.
   PubMed Web of Science ®Google Scholar
• More SV, Kumar H, Cho D-Y, et al. Toxin-induced experimental models of learning and memory impairment. IJMS. 2016;17(9):1447.
   Google Scholar
• Kumar A, Pintus F, Di Petrillo A, et al. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease. Sci Rep. 2018;8(1):4424.
   PubMedGoogle Scholar
• Saraceno C, Musardo S, Marcello E, et al. Modeling Alzheimer’s disease: from past to future. Front Pharmacol. 2013;4:77–77.
   PubMed Web of Science ®Google Scholar
• Moreira EL, de Oliveira J, Engel DF, et al. Hypercholesterolemia induces short-term spatial memory impairments in mice: up-regulation of acetylcholinesterase activity as an early and causal event? J Neural Transm (Vienna). 2014;121(4):415–426.
   PubMed Web of Science ®Google Scholar
• Wang D, Liu L, Li S, et al. Effects of paeoniflorin on neurobehavior, oxidative stress, brain insulin signaling, and synaptic alterations in intracerebroventricular streptozotocin-induced cognitive impairment in mice. Physiol Behav. 2018;191:12–20.
   PubMed Web of Science ®Google Scholar
• Llorens-Martin M, Jurado J, Hernandez F, et al. GSK-3beta, a pivotal kinase in Alzheimer disease. Front Mol Neurosci. 2014;7:46.
   PubMed Web of Science ®Google Scholar